Correlation Between Achilles Therapeutics and Vincerx Pharma

Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Achilles Therapeutics PLC and Vincerx Pharma, you can compare the effects of market volatilities on Achilles Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Vincerx Pharma.

Diversification Opportunities for Achilles Therapeutics and Vincerx Pharma

-0.81

Correlation Coefficient

Achilles Therapeutics  Vincerx Pharma

Pay attention - limited upside

The 3 months correlation between Achilles and Vincerx is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Vincerx Pharma

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.37 times more return on investment than Vincerx Pharma. However, Achilles Therapeutics PLC is 2.72 times less risky than Vincerx Pharma. It trades about 0.15 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.43 per unit of risk. If you would invest  118.00  in Achilles Therapeutics PLC on December 28, 2024 and sell it today you would earn a total of  30.00  from holding Achilles Therapeutics PLC or generate 25.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	91.8%
Values	Daily Returns

Achilles Therapeutics PLC  vs.  Vincerx Pharma

Achilles Therapeutics PLC

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Achilles Therapeutics and Vincerx Pharma

The main advantage of trading using opposite Achilles Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.

The idea behind Achilles Therapeutics PLC and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.